The autumn meeting of the European Alzheimer's Disease Consortium (EADC) commenced with introductory remarks from Frank Jessen and Sebastiaan Engelborghs, Chair and co-Chair of the EADC. The EADC is a network of clinical centres of excellence in dementia research and treatment, comprising memory clinics and institutions from 20 countries across Europe. Key presentations on day one included lectures from Federica Ribaldi (Hopitaux Universitaires de Geneve/HUG) on cognitive health initiatives in Geneva, and Claire Chevalier (HUG) on the development of a probiotics platform for Alzheimer’s Disease. Industry experts presented cutting-edge findings on plasma biomarkers and from clinical trials, followed by a special lecture from Sebastian Palmqvist (Lund University) highlighting the value of plasma biomarkers in primary care.
The day concluded with a symposium on ageing and senescence, featuring discussions on geroscience and neuroimaging. On 8 October, the focus shifted to young researcher presentations and new initiatives, with discussions on future plans for meetings and collaborations. The meeting concluded with the award of the first individual EADC membership to Bengt Winblad, Professor of Neurogeriatrics at the Department of Neurobiology, Care Sciences and Society at the Karolinska Institutet. Bengt has had a long and hugely productive research career in the Alzheimer's disease field, and chaired the EADC between 2001 and 2019, expanding its membership to over 60 centres of research excellence.